Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Strander

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
Acta Medica Scandinavica|January 1, 1979
Interferon therapy in multiple myelomaK Ideström, K Cantell, D Killander, et al.
International Journal of Cancer|August 15, 1982
Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-alphaS Einhorn, A Ahre, H Blomgren, et al.
Scandinavian Journal of Haematology|January 1, 1984
Interferon-alpha treatment of a patient with acute lymphoblastic leukaemia and Down's syndrome. Effects on natural killer cell activity and mitogen responsivenessG Bratt, S Einhorn, H Blomgren, et al.
Lancet (London, England)|February 3, 1979
Interferon therapy in myelomatosisH Mellstedt, A Ahre, M Björkholm, et al.
Annals of Clinical and Laboratory Science|January 1, 1984
Interferon as a modifier of estrogen receptorsN V Dimitrov, C J Meyer, H Strander, et al.
The Journal of Infectious Diseases|June 1, 1976
Acute infections in interferon-treated patients with osteosarcoma: preliminary report of a comparative studyH Strander, K Cantell, G Carlström, et al.
Clinical and Experimental Immunology|October 1, 1977
Acute energy deprivation in man: effect on serum immunoglobulins antibody response, complement factors 3 and 4, acute phase reactants and interferon-producing capacity of blood lymphocytesJ Palmblad, K Cantell, G Holm, et al.
Archives of Virology|January 1, 1978
Lack of correspondence between virus-induced human leukocyte interferon and concanavalin A-induced human migration inhibitory factor (MIF)L H Block, K Cantell, S Bamberger, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: a randomized phase II studyU Ringborg, C M Rudenstam, J Hansson, et al.
Journal of Interferon Research|January 1, 1984
Effect of interferon on heterotopic new bone formation in miceO S Nilsson, F C Bauer, L A Broström, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
Acta Medica Scandinavica|January 1, 1979
Interferon therapy in multiple myelomaK Ideström, K Cantell, D Killander, et al.
International Journal of Cancer|August 15, 1982
Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-alphaS Einhorn, A Ahre, H Blomgren, et al.
Scandinavian Journal of Haematology|January 1, 1984
Interferon-alpha treatment of a patient with acute lymphoblastic leukaemia and Down's syndrome. Effects on natural killer cell activity and mitogen responsivenessG Bratt, S Einhorn, H Blomgren, et al.
Lancet (London, England)|February 3, 1979
Interferon therapy in myelomatosisH Mellstedt, A Ahre, M Björkholm, et al.
Annals of Clinical and Laboratory Science|January 1, 1984
Interferon as a modifier of estrogen receptorsN V Dimitrov, C J Meyer, H Strander, et al.
The Journal of Infectious Diseases|June 1, 1976
Acute infections in interferon-treated patients with osteosarcoma: preliminary report of a comparative studyH Strander, K Cantell, G Carlström, et al.
Clinical and Experimental Immunology|October 1, 1977
Acute energy deprivation in man: effect on serum immunoglobulins antibody response, complement factors 3 and 4, acute phase reactants and interferon-producing capacity of blood lymphocytesJ Palmblad, K Cantell, G Holm, et al.
Archives of Virology|January 1, 1978
Lack of correspondence between virus-induced human leukocyte interferon and concanavalin A-induced human migration inhibitory factor (MIF)L H Block, K Cantell, S Bamberger, et al.
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: a randomized phase II studyU Ringborg, C M Rudenstam, J Hansson, et al.
Journal of Interferon Research|January 1, 1984
Effect of interferon on heterotopic new bone formation in miceO S Nilsson, F C Bauer, L A Broström, et al.
Pageof 12